Skip to content

Clinical trials

Huntington Disease trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Huntington Disease Country / region: Germany Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20093
20114
20122
20145
20153
20174
20183
20192
20203
20212
20222
20233
20242
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated9
Recruiting7
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche5
Novartis Pharmaceuticals5
Prilenia5
Wave Life Sciences USA, Inc.5
CHDI Foundation, Inc.2
Charite University, Berlin, Germany2
European Huntington's Disease Network2
Heinrich-Heine University, Duesseldorf2
Pfizer2
Siena Biotech S.p.A.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Huntington Disease44
Chorea6
Neurodegenerative Diseases4
Dyskinesias2
Movement Disorders2
Rare Diseases2
Basal Ganglia Diseases1
Brain Diseases1
Central Nervous System Diseases1
Cognition Disorders1

Trials

Showing 26 to 44 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.